CFMS News and Press, Conformis Inc. From 09/02/20

BILLERICA, Mass., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and members of the Company’s executive management team will participate in the 2020 Wells Fargo Virtual Healthcare Conference t...

Conformis ( CFMS -2.4% ) has completed the second of three milestones related to the license and development agreement with Stryker ( SYK +1.1% ) , under which Conformis is developing patient-specific instrumentation (PSI) for use in Stryker’s knee implant offerings. Mor...

BILLERICA, Mass., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it completed the second of three milestones pursuant to the License Agreement and Development Agreement with Howmedica Osteonics Corp., a wholly owned subsidiary of Stryker Corporation als...

The following slide deck was published by Conformis, Inc. in conjunction with this Read more ...

BILLERICA, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed Farzin Khaghani as its new VP, US Marketing. “We are very pleased to announce that Farzin Khaghani has rejoined our team as VP, US Marketing. Farzin...

BILLERICA, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that 90% of the patients studied in peer-reviewed clinical research published online in The Journal of Bone and Joint Surgery Reviews were satisfied, or very satisfied, 18–28 months post...

Conformis, Inc. (CFMS) Q2 2020 Earnings Conference Call August 5, 2020 4:30 PM ET Company Participants Mark Augusti – President and Chief Executive Officer Bob Howe – Chief Financial Officer Conference Call Participants Josh Jennings – Cowen Presentati...

ConforMIS (NASDAQ: CFMS ) : Q2 GAAP EPS of -$0.03 beats by $0.02 . More news on: Conformis, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

BILLERICA, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the second quarter ended June 30, 2020. Second Quarter 2020 Summary Total revenue of $19.5 million, a decrease of 1% year-over-year on a reported and constant...

Background: I am an orthopedic surgeon in a busy practice. I have used Flexion's (FLXN) knee arthritis product Zilretta clinically, and I have met with the sales representative from Flexion on three occasions. I have performed approximately 20 Zilretta injections. I do not think the proponents...